BCM
AGN

Brooktree Capital Management’s Allergan plc AGN Stock Holding History

Brooktree Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,836
Closed -$325K – 103
2020
Q1 		$325K Sell
1,836
-113
-6% -$21.3K 0.38% 43
2019
Q4 		$373K Buy
+1,949
New +$352K 0.34% 45

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Brooktree Capital Management's AGN Position: Q2 2020 in Review

Brooktree Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,836 shares — an estimated $325K sold.

Brooktree Capital Management first reported a position in AGN in Q4 2019 and held it in 2 quarters. The position peaked at $373K in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Brooktree Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Brooktree Capital Management sold 1,836 Allergan plc shares in Q2 2020, an estimated $325K.
  • Brooktree Capital Management first reported a position in Allergan plc in Q4 2019 and held it in 2 quarters.
  • Brooktree Capital Management's Allergan plc position peaked at $373K in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Brooktree Capital Management's 13F filing for Q2 2020, filed 3 Aug 2020.